Exploring foci of
2020-11-04
Interaction of amyloid beta with humanin and acetylcholinesterase is modulated by ATP
2020-11-04 • Sarah Atali, Sadaf Dorandish, Jonathan Devos, Asana Williams, Deanna Price, Jaylen E. Taylor, Jeffrey Guthrie, Deborah Heyl, Hedeel Guy Evans
Humanin (HN) is known to bind amyloid beta (Aβ)‐inducing cytoprotective effects, while binding of acetylcholinesterase (AChE) to Aβ increases its aggregation and cytotoxicity. Previously, we showed that binding of HN to Aβ blocks aggregation induced by AChE and that HN decreases but does not abolish Aβ‐AChE interactions in A549 cell media. Here, we set out to shed light on factors that modulate the interactions of Aβ with HN and AChE. We found that binding of either HN or AChE to Aβ is not affected by heparan sulf…
Catenin Beta-1
Cerebral Amyloid Angiopathy
Interleukin 1 Beta
Beta-Carotene
Phi Beta Sigma
Interferon Beta-1A
Protein–Protein Interaction
Beta-Actin
Tgf Beta 1
Exploring foci of
2020-06-27
Biochemical determinants of the IGFBP‐3–hyaluronan interaction
2020-06-27 • Sadaf Dorandish, Jonathan Devos, Bradley Clegg, Deanna Price, Robert Muterspaugh, Jeffrey Guthrie, Deborah Heyl, Hedeel Guy Evans
IGFBP‐3, the most abundant IGFBP and the main carrier of insulin‐like growth factor I (IGF‐I) in the circulation, can bind IGF‐1 with high affinity, which attenuates IGF/IGF‐IR interactions, thereby resulting in antiproliferative effects. The C‐terminal domain of insulin‐like growth factor‐binding protein‐3 (IGFBP‐3) is known to contain an 18‐basic amino acid motif capable of interacting with either humanin (HN) or hyaluronan (HA). We previously showed that the 18‐amino acid IGFBP‐3 peptide is capable of binding e…
Biochemical Oxygen Demand
Social Determinants Of Health
Commercial Determinants Of Health